Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71610-032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 500mg (71610 032 53)

Bottle Label 500mg (71610 032 53)
This is a bottle of Divalproex Sodium Delayed-Release tablets with a strength of 500mg and 60 tablets in the bottle. The brand name on the label appears to be "Ovalproex Sodum Delayed-Release", however, there seems to be a typo where the "d" is missing from "Sodium".*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Chemical Structure (Divalproex 01)

Chemical Structure (Divalproex 01)
FDA Label Image

Figure 1 (Divalproex 02)

Figure 1 (Divalproex 02)
The text represents the results of two studies (Study 1 and Study 2) using the YMRS and MRS scales. The percentage values may indicate the level of severity of some conditions or symptoms measured by the scales. Other than that, no other information is available to determine the exact nature of the studies or their purpose.*
FDA Label Image

Figure 2 (Divalproex 03)

Figure 2 (Divalproex 03)
This appears to be a list of medication names, but there is no useful description that can be generated from it without additional context.*
FDA Label Image

Figure 3 (Divalproex 04)

Figure 3 (Divalproex 04)
This document appears to be a representation of a chart or graph showing the percentage reduction in CPS (compound per second) rate for high and low dose cases. The chart also shows the percentage of patients who experienced improvement, no change, or worsening. It is unclear what the data is describing and what the units are.*
FDA Label Image

Figure 4 (Divalproex 05)

Figure 4 (Divalproex 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.